UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients

CNS & neurological disorders drug targets, 2013-02, Vol.12 (1), p.104-111

2013

Volltextzugriff (PDF)

Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression

Immunobiology (1979), 2016-02, Vol.221 (2), p.193-198

2016

Volltextzugriff (PDF)

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood

Atherosclerosis, 2013-08, Vol.229 (2), p.338-347

2013

Volltextzugriff (PDF)

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

Journal of neuroinflammation, 2010-10, Vol.7 (1), p.72-72

2010

Volltextzugriff (PDF)

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke

Journal of stroke and cerebrovascular diseases, 2016-02, Vol.25 (2), p.327-334

2016

Volltextzugriff (PDF)

Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

Neuromolecular medicine, 2016-03, Vol.18 (1), p.16-36

Sternberg, Zohara

2016

Volltextzugriff (PDF)

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta

Journal of neuroinflammation, 2009-10, Vol.6 (1), p.28-28

2009

Volltextzugriff (PDF)

Transvascular Autonomic Modulation: A Modified Balloon Angioplasty Technique for the Treatment of Autonomic Dysfunction in Multiple Sclerosis Patients

Journal of endovascular therapy, 2014-06, Vol.21 (3), p.417-428

2014

Volltextzugriff (PDF)

Mechanical ventilation down-regulates surfactant protein a and keratinocyte growth factor expression in premature rabbits

Pediatric research, 2007-09, Vol.62 (3), p.277-282

2007

Volltextzugriff (PDF)

Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen

Journal of stroke and cerebrovascular diseases, 2013-08, Vol.22 (6), p.725-732

2013

Volltextzugriff (PDF)

Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients

Neuropharmacology, 2018-03, Vol.130, p.71-76

2018

Volltextzugriff (PDF)

Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis

Cardiovascular therapeutics, 2014-04, Vol.32 (2), p.33-39

2014

Volltextzugriff (PDF)

High-mobility group box 1 in multiple sclerosis

Immunologic research, 2016-04, Vol.64 (2), p.385-391

2016

Volltextzugriff (PDF)

Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis

Journal of neuroimmunology, 2014-09, Vol.274 (1), p.197-201

2014

Volltextzugriff (PDF)

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects

Atherosclerosis, 2013-12, Vol.231 (2), p.411-420

2013

Volltextzugriff (PDF)

AGE-RAGE in Multiple Sclerosis Brain

Immunological investigations, 2011, Vol.40 (2), p.197-205

2011

Volltextzugriff (PDF)

Quercetin and interferon-β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients

Journal of neuroimmunology, 2008-12, Vol.205 (1), p.142-147

2008

Volltextzugriff (PDF)

Blood pressure normalization post-jugular venous balloon angioplasty

Phlebology, 2015-05, Vol.30 (4), p.280-287

2015

Volltextzugriff (PDF)

Plasma pentosidine: a potential biomarker in the management of multiple sclerosis

Multiple sclerosis, 2011-02, Vol.17 (2), p.157-163

2011

Volltextzugriff (PDF)

Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis

Journal of clinical immunology, 2012-06, Vol.32 (3), p.497-504

2012

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients

Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke

Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta

Transvascular Autonomic Modulation: A Modified Balloon Angioplasty Technique for the Treatment of Autonomic Dysfunction in Multiple Sclerosis Patients

Mechanical ventilation down-regulates surfactant protein a and keratinocyte growth factor expression in premature rabbits

Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen

Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients

Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis

High-mobility group box 1 in multiple sclerosis

Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects

AGE-RAGE in Multiple Sclerosis Brain

Quercetin and interferon-β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients

Blood pressure normalization post-jugular venous balloon angioplasty

Plasma pentosidine: a potential biomarker in the management of multiple sclerosis

Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis

Aktive Filter

Suchergebnisse filtern